Antisense oligonucleotide therapy for spinocerebellar ataxia type 2.
Nature. 2017 Apr 20;544(7650):362-366. doi: 10.1038/nature22044. Epub 2017 Apr 12.
Nature. 2017.
PMID: 28405024
Free PMC article.